Inpatient Treatment for Uncomplicated and Complicated Acute Pelvic Inflammatory Disease: Ampicillin/Sulbactam Vs. Cefoxitin

Objective: Ampicillin plus sulbactam, an irreversible β-lactamase inhibitor, was compared to cefoxitin in the treatment of women with acute pelvic inflammatory disease (PID) with and without inflammatory mass(es). Methods: Participation in an open, prospective, randomized clinical trial was offered...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemsell, David L., Wendel, George D., Hemsell, Patricia G., Heard, Molly L., Nobles, Brenda J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364305/
https://www.ncbi.nlm.nih.gov/pubmed/18475331
http://dx.doi.org/10.1155/S1064744993000286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364305/
https://www.ncbi.nlm.nih.gov/pubmed/18475331
http://dx.doi.org/10.1155/S1064744993000286

Ejemplares similares